Openfund

CORDIS · AIMed

Antimicrobial Integrated Methodologies for orthopaedic applications

Код
AIMed
Програма
H2020
Процедура
MSCA-ITN-2019
Статус
CLOSED
Период
01.01.2020 – 31.12.2024
Обща стойност (целият консорциум)3 845 532 €
Принос на ЕС (целият консорциум)3 845 532 €
Принос на ЕС за българските участници617 127 €

Официални данни · CORDIS · синхронизирано 17.10.2026 10:16 · официален запис

Участници

ОрганизацииРоляДържаваБезвъзмездна помощ
THE UNIVERSITY OF BIRMINGHAMкоординаторUK909 518 €
ИНСТИТУТ ПО ЕЛЕКТРОНИКА - БАНучастникBG617 127 €
FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBERGучастникDE442 380 €
UNIVERSITE DE TOULOUSEучастникFR274 802 €
INSTITUT NATIONAL POLYTECHNIQUE DE TOULOUSEучастникFR274 802 €
UNIVERSITE POLYTECHNIQUE HAUTS-DE-FRANCEучастникFR274 802 €
UNIVERSITA DEGLI STUDI DI TRIESTEучастникIT261 500 €
PHOTON ENERGY GmbHучастникDE252 788 €
UNIVERSIDADE DO PORTOучастникPT237 720 €
RUDER BOSKOVIC INSTITUTEучастникHR237 367 €
REGEMAT 3D SOCIEDAD LIMITADAучастникES62 726 €
UNIVERSITY OF LIMERICKучастникIE0 €

Описание

The AIMed network, consisting of 12 beneficiaries and 6 partner organisations, will develop a range of materials with anti-bacterial properties that are suitable for use on the surfaces of orthopaedic implants. This is in response to the increasing problem of post-operative infection by antibiotic-resistant bacteria. By combining several approaches to disrupt surface biofilm formation, the materials developed by the AIMed network will eventually result in fewer surgical infections, faster recovery of patients, and greatly reduced post-operative healthcare costs. The network will develop novel peptide sequences and ways of binding them to the surfaces of olymers, ceramics and metals. A complementary approach will be the developent of metal ion substituted calcium phosphate coatings which can be applied to implants by additive manufacturing techniques. The efficacy of these anti-bacterial surfaces will be further enhanced by laser processing of the material to make it unattractive to biofilms (by altering the roughness and wetting characteristics). The network will carry out a thorough investigation of the properties of the new materials to ensure that they are feasible for use in future implants. This work will include the evaluation of antibacterial action and biocompatibility using appropriate models. Training of the 15 ESR's appointed to the network will be multi-disciplinary and intersectoral, with an emphasis on the need for technology transfer from academic institutions to commercial users.

Официални данни · CORDIS · синхронизирано 17.10.2026 10:16 · официален запис · Лиценз: © European Union, CC BY 4.0 (Commission reuse policy).